- Home
- PLX vs BFIN Comparison
PLX vs BFIN Comparison
Compare PLX & BFIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLX
- BFIN
- Stock Information
- Founded
- PLX 1993
- BFIN 1924
- Country
- PLX Israel
- BFIN United States
- Employees
- PLX N/A
- BFIN N/A
- Industry
- PLX Biotechnology: Biological Products (No Diagnostic Substances)
- BFIN Savings Institutions
- Sector
- PLX Health Care
- BFIN Finance
- Exchange
- PLX Nasdaq
- BFIN Nasdaq
- Market Cap
- PLX 160.2M
- BFIN 162.9M
- IPO Year
- PLX 1998
- BFIN N/A
- Fundamental
- Price
- PLX $2.59
- BFIN $12.82
- Analyst Decision
- PLX Strong Buy
- BFIN
- Analyst Count
- PLX 1
- BFIN 0
- Target Price
- PLX $15.00
- BFIN N/A
- AVG Volume (30 Days)
- PLX 764.3K
- BFIN 14.3K
- Earning Date
- PLX 03-17-2025
- BFIN 05-08-2025
- Dividend Yield
- PLX N/A
- BFIN 3.17%
- EPS Growth
- PLX N/A
- BFIN N/A
- EPS
- PLX 0.04
- BFIN 0.33
- Revenue
- PLX $53,399,000.00
- BFIN $49,098,000.00
- Revenue This Year
- PLX $67.17
- BFIN $2.37
- Revenue Next Year
- PLX $55.31
- BFIN $8.53
- P/E Ratio
- PLX $71.07
- BFIN $38.58
- Revenue Growth
- PLX N/A
- BFIN N/A
- 52 Week Low
- PLX $0.82
- BFIN $9.60
- 52 Week High
- PLX $2.76
- BFIN $13.97
- Technical
- Relative Strength Index (RSI)
- PLX 58.97
- BFIN 50.11
- Support Level
- PLX $2.43
- BFIN $12.61
- Resistance Level
- PLX $2.62
- BFIN $12.99
- Average True Range (ATR)
- PLX 0.14
- BFIN 0.34
- MACD
- PLX 0.02
- BFIN -0.01
- Stochastic Oscillator
- PLX 85.00
- BFIN 32.14
About PLX Protalix BioTherapeutics Inc. (DE)
Protalix BioTherapeutics Inc is a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx protein expression system or ProCellEx. It has developed taliglucerase alfa for the treatment of Gaucher disease. The company's products also treat diseases like Fabry disease and cystic fibrosis. The company's primary sources of revenue include its sales of BioManguinhos alfataliglicerase in Brazil and of drug substances to Pfizer under its Amended Pfizer Agreement. The company's pipeline consists of ELFABRIO, Uricase, and Long Acting DNase I.
About BFIN BankFinancial Corporation
BankFinancial Corp is a national bank principally engaged in the business of commercial, family and personal banking. It offers customers a broad range of loan, deposit, trust and other financial products and services. The Bank offers customers a broad range of loan, deposit, trust and other financial products and services through all full-service banking offices located in Cook, DuPage, Lake and Will Counties, Illinois and through Internet Branch.